Abstract
To realize the potential of revolutionary cell therapy treatments, challenges of safety and cost must be addressed. Scale-up of cell manufacture is a key approach to mitigating these issues. CTS™ DynaCellect™ for the isolation and debeading of cells and stirred tank bioreactors for cell culture are two scalable building blocks for cell therapy manufacturing processes that can help combat common industry challenges. 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.